Cambridge Cognition Holdings Plc (AIM:COG)
30.75
-0.75 (-2.38%)
Dec 5, 2025, 2:31 PM GMT+1
AIM:COG Market Cap
AIM:COG has a market cap or net worth of 13.19 million as of December 5, 2025. Its market cap has increased by 14.35% in one year.
Market Cap
13.19M
Enterprise Value
14.25M
Revenue
9.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.75
Market Cap Chart
Since April 18, 2013, AIM:COG's market cap has increased from 13.12M to 13.19M, an increase of 0.54%. That is a compound annual growth rate of 0.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 13.19M | -15.54% |
| Dec 31, 2024 | 15.61M | -2.50% |
| Dec 29, 2023 | 16.01M | -54.81% |
| Dec 30, 2022 | 35.44M | -9.78% |
| Dec 31, 2021 | 39.28M | 88.84% |
| Dec 31, 2020 | 20.80M | 208.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 209.56B |
| GSK plc | 73.29B |
| Haleon | 32.02B |
| Smith & Nephew | 10.44B |
| Convatec Group | 4.45B |
| Hikma Pharmaceuticals | 3.52B |
| HUTCHMED (China) | 1.84B |
| Genus | 1.77B |